Why Are ALB Shares Falling Today?

By Chris Stiles • Friday, August 25 12:59 • Permanent Link

This afternoon we watched Albemarle drop -1.0% to a price of $188.84 per share. The large-cap Chemicals company is now trading -28.57% below its average target price of $264.36. Analysts have set target prices ranging from $155.0 to $360.0 per share for Albemarle, and have given the stock an average rating of buy.

Albemarle has an average level of shares sold short, at 5.7% of its total share float. The stock's short ratio (also called days to cover) is 3.43. The company's insiders own 0.23% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 89.7% of Albemarle's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Albemarle

Date Reported	Holder	Percentage	Shares	Value
2023-06-30	Vanguard Group Inc	12%	14,039,343	$2,651,189,480
2023-06-30	Blackrock Inc.	9%	10,157,015	$1,918,050,675
2023-06-30	State Street Corporation	4%	5,242,800	$990,050,332
2023-06-30	Bank of America Corporation	4%	5,117,596	$966,406,809
2023-06-30	Capital Research Global Investors	3%	3,381,656	$638,591,906
2023-06-30	Franklin Resources, Inc.	3%	3,135,732	$592,151,619
2023-06-30	Baillie Gifford and Company	2%	2,494,230	$471,010,384
2023-06-30	Geode Capital Management, LLC	2%	2,481,901	$468,682,175
2023-06-30	Capital International Investors	2%	2,267,914	$428,272,871
2023-06-30	Primecap Management Company	2%	2,099,025	$396,379,873

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.